Bausch & Lomb (BLCO) Cash from Operations (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Cash from Operations came in at $153.0 million in Q2 2026, up 337.14% on a YoY basis from $35.0 million in Q2 2025, and up 378.12% quarter-over-quarter from $32.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Cash from Operations (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Cash from Operations for 6 consecutive years, with $153.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Operations rose 337.14% year-over-year to $153.0 million; the trailing twelve-month figure through Jun 2026 stood at $458.0 million (up 146.24% YoY), and the FY2025 full-year result was $283.0 million, up 21.98% from the prior year.
- Cash from Operations advanced to $153.0 million in Q2 2026 per BLCO's latest filing, from $32.0 million in the prior quarter.
- Across five years, Cash from Operations topped out at $159.0 million in Q4 2022 and bottomed at -$56.0 million in Q1 2023.
- Historically, Cash from Operations has averaged $57.1 million across 5 years, with a median of $33.5 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations sank 1966.67% in 2023, then soared 518.18% in 2025.
- Over 5 years, Cash from Operations stood at $159.0 million in 2022, then plunged by 90.57% to $15.0 million in 2023, then soared by 46.67% to $22.0 million in 2024, then jumped by 518.18% to $136.0 million in 2025, then gained by 12.5% to $153.0 million in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered $153.0 million, $32.0 million, and $136.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 153.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153.00 Mn |
| Mar 31, 2026 | 32.00 Mn |
| Dec 31, 2025 | 136.00 Mn |
| Sep 30, 2025 | 137.00 Mn |
| Jun 30, 2025 | 35.00 Mn |
| Mar 31, 2025 | -25.00 Mn |
| Dec 31, 2024 | 22.00 Mn |
| Sep 30, 2024 | 154.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 41.00 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 48.00 Mn |
| Jun 30, 2023 | -24.00 Mn |
| Mar 31, 2023 | -56.00 Mn |
| Dec 31, 2022 | 159.00 Mn |
| Sep 30, 2022 | 27.00 Mn |
| Jun 30, 2022 | 156.00 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 162.00 Mn |
| Sep 30, 2021 | 273.00 Mn |